Natalia A. Muraleva
Siberian Branch Of Russian Academy Of Sciences, 10 Lavrentyeva Ave
Novosibirsk, NVS 630090, Russian Federation
Novosibirsk, NVS 630090, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in db/db Diabetic Mice.
Journal: International journal of molecular sciences
Published: April 30, 2026
Features of Alteration in MAPK Pathway Activity in the Postnatal Brain of a Rat Model of Sporadic Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: April 16, 2026
Mitochondria in Developing Brain: Contribution of Deviations to Higher Susceptibility to Neurodegeneration in Latter Periods of Life.
Journal: Biochemistry. Biokhimiia
Published: December 26, 2025
JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer's Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S.
Journal: Biochemistry. Biokhimiia
Published: April 20, 2025
Empagliflozin Alleviates Changes in Renal Expression of E- and N-Cadherins in Mice with Type 2 Diabetes Mellitus.
Journal: Bulletin of experimental biology and medicine
Published: April 10, 2025
Retinoprotective Effect of SkQ1, Visomitin Eye Drops, Is Associated with Suppression of P38 MAPK and ERK1/2 Signaling Pathways Activity.
Journal: Biochemistry. Biokhimiia
Published: April 15, 2024
P38 MAPK Signaling in the Retina: Effects of Aging and Age-Related Macular Degeneration.
Journal: International journal of molecular sciences
Published: June 23, 2023
Alteration of the MEK1/2-ERK1/2 Signaling Pathway in the Retina Associated with Age and Development of AMD-Like Retinopathy.
Journal: Biochemistry. Biokhimiia
Published: April 18, 2023
SkQ1 as a Tool for Controlling Accelerated Senescence Program: Experiments with OXYS Rats.
Journal: Biochemistry. Biokhimiia
Published: January 30, 2023
MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer's Disease: A Study in Senescence-Accelerated OXYS Rats.
Journal: Antioxidants (Basel, Switzerland)
Published: June 02, 2021
SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer's Disease-Like Pathology in OXYS Rats.
Journal: Antioxidants (Basel, Switzerland)
Published: June 11, 2020
Last Updated: 09/26/2026